Trials / Completed
CompletedNCT01628536
A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesize that black cohosh, as a potentially therapeutic agent, will reduce the overall size and aggressiveness of ductal carcinoma in situ (DCIS) when given in a pre-operative setting.
Detailed description
The overarching hypothesis of our research is that black cohosh has potential to be a well-tolerated, effective agent for the treatment of early breast cancer. This pilot study represents a first step in exploring this hypothesis by demonstrating preliminary evidence of specific anti-tumor effect of black cohosh on areas of ductal carcinoma in situ (DCIS) in the breast.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Black cohosh | Remifemin 20 mg tablet orally twice per day x 4 weeks |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2016-01-14
- Completion
- 2016-06-01
- First posted
- 2012-06-26
- Last updated
- 2023-10-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01628536. Inclusion in this directory is not an endorsement.